DAIENCE LIMITED

Executive Summary

DAIENCE LIMITED, a newly established micro-entity in the publishing and internet retail sector, currently exhibits negative net current assets, indicating immediate liquidity and solvency risks. While regulatory compliance is satisfactory, the limited financial history and small operational scale warrant cautious scrutiny. Further due diligence on liabilities, funding plans, and cash flow projections is essential to assess the company’s operational sustainability.

DAIENCE LIMITED - Analysis Report

Company Number: 14762223

Analysis Date: 2025-07-20 18:25 UTC

1. Risk Rating: HIGH
   The company’s financial position as of 31 March 2024 shows net current liabilities of £191 (negative net current assets), indicating an immediate solvency concern. With current liabilities exceeding current assets and a negative net asset balance, this micro-entity appears unable to meet short-term obligations from available liquid resources.

2. Key Concerns:

• Negative net current assets (£-191) signal potential liquidity issues that could impair operational continuity without additional funding.
• The company is newly incorporated (March 2023) with limited operating history and minimal financial data, restricting the ability to assess sustainable business performance.
• Only one employee reported, which may reflect limited operational scale and dependency on key personnel or external service providers, increasing operational risk.

3. Positive Indicators:

• The company is compliant with filing deadlines for both accounts and confirmation statements, indicating good regulatory compliance to date.
• Directors and persons with significant control are clearly identified with no reported disqualifications or governance issues.
• The company’s industry classification (publishing and internet retail) can offer scalable growth opportunities if operationally executed effectively.

4. Due Diligence Notes:

• Investigate the nature and timing of current liabilities to understand if they are trade payables, loans, or other obligations and assess plans to address the negative working capital.
• Review any capital injections, shareholder loans, or other funding sources post 31 March 2024 to evaluate liquidity improvements.
• Obtain management accounts or cash flow projections to assess near-term operational viability and funding requirements.
• Confirm no outstanding regulatory or legal issues beyond what is publicly filed.
• Assess the business model and revenue generation strategy given the micro scale and early stage of the company.